Malignant neoplasm of unspecified kidney, except renal pelvis. Malignant neoplasm of urinary organ, unspecified
|
|
|
- Kristin Watson
- 7 years ago
- Views:
Transcription
1 ICD-10 CODE GUIDE
2 These codes are provided for reference and this list does not contain all possible applicable codes. Codes should be chosen based on the patient s relevant family and personal history and multiple codes may be selected. C64.9 C65.9 C66.9 C67.9 C68.9 D09.0 D09.10 D09.19 Z80.51 Z80.52 Z80.59 Z85.50 Z85.51 Z Z Z85.53 Z85.54 Z85.59 Bladder/Renal Malignant neoplasm of unspecified kidney, except renal pelvis Malignant neoplasm of unspecified renal pelvis Malignant neoplasm of unspecified ureter Malignant neoplasm of bladder, unspecified Malignant neoplasm of urinary organ, unspecified Carcinoma in situ of bladder Carcinoma in situ of unspecified urinary organ Carcinoma in situ of other urinary organs Family history of malignant neoplasm of kidney Family history of malignant neoplasm of bladder Family history of malignant neoplasm of other urinary tract organ Personal history of malignant neoplasm of unspecified urinary tract organ Personal history of malignant neoplasm of bladder Personal history of malignant carcinoid tumor of kidney Personal history of other malignant neoplasm of kidney Personal history of malignant neoplasm of renal pelvis Personal history of malignant neoplasm of ureter Personal history of malignant neoplasm of other urinary tract organ C C C56.9 D05.00 Breast / Ovarian Malignant neoplasm of unspecified site of unspecified female breast Malignant neoplasm of unspecified site of unspecified male breast Malignant neoplasm of unspecified ovary Lobular carcinoma in situ of unspecified breast Page 1/7
3 D05.10 D05.90 D07.30 Z15.01 Z15.02 Z15.03 Z80.3 Z80.41 Z80.42 Z85.3 Z85.43 Breast / Ovarian continued Intraductal carcinoma in situ of unspecified breast Unspecified type of carcinoma in situ of unspecified breast Carcinoma in situ of unspecified female genital organs Genetic susceptibility to malignant neoplasm of breast Genetic susceptibility to malignant neoplasm of ovary Genetic susceptibility to malignant neoplasm of prostate Family history of malignant neoplasm of breast Family history of malignant neoplasm of ovary Family history of malignant neoplasm of prostate Personal history of malignant neoplasm of breast Personal history of malignant neoplasm of ovary C18.9 C19 C20 C21.0 D01.0 D01.1 D01.2 D01.3 D01.40 D01.7 D01.9 K63.5 Malignant neoplasm of colon, unspecified Malignant neoplasm of rectosigmoid junction Malignant neoplasm of rectum Malignant neoplasm of anus, unspecified Carcinoma in situ of colon Carcinoma in situ of rectosigmoid junction Carcinoma in situ of rectum Carcinoma in situ of anus and anal canal Carcinoma in situ of unspecified part of intestine Colorectal Carcinoma in situ of other specified digestive organs Carcinoma in situ of digestive organ, unspecified Polyp of colon Page 2/7
4 Z83.71 Z83.79 Z85.00 Z Colorectal continued Family history of colonic polyps Family history of other diseases of the digestive system Personal history of malignant neoplasm of unspecified digestive organ Personal history of colonic polyps C70.0 C70.1 C70.9 C73 C75.0 C75.1 C75.9 D09.3 D17.9 D34 D35.9 D42.9 E21.5 E23.7 Z15.81 Z83.41 Z83.49 Z Z Malignant neoplasm of cerebral meninges Malignant neoplasm of spinal meninges Malignant neoplasm of meninges, unspecified Malignant neoplasm of thyroid gland Malignant neoplasm of parathyroid gland Malignant neoplasm of pituitary gland Benign neoplasm of thyroid glands Disorder of pituitary gland, unspecified Endocrine Malignant neoplasm of endocrine gland, unspecified Carcinoma in situ of thyroid and other endocrine glands Benign lipomatous neoplasm, unspecified Benign neoplasm of endocrine gland, unspecified Neoplasm of uncertain behavior of meninges, unspecified Disorder of parathyroid gland, unspecified Genetic susceptibility to multiple endocrine neoplasia [MEN] Family history of multiple endocrine neoplasia [MEN] syndrome Family history of other endocrine, nutritional and metabolic diseases Personal history of malignant neoplasm of thyroid Personal history of malignant neoplasm of other endocrine glands Page 3/7
5 C18.9 C54.1 C55 C56.9 D07.0 Z15.04 Z80.3 Z80.41 Z80.49 Z85.00 Z85.3 Z85.43 Z85.44 Malignant neoplasm of colon, unspecified Malignant neoplasm of endometrium Malignant neoplasm of uterus, part unspecified Malignant neoplasm of unspecified ovary Carcinoma in situ of endometrium Family history of malignant neoplasm of breast Personal history of malignant neoplasm of breast Endometrial / Uterine Genetic susceptibility to malignant neoplasm of endometrium Family history of malignant neoplasm of ovary Family history of malignant neoplasm of other genital organs Personal history of malignant neoplasm of unspecified digestive organ Personal history of malignant neoplasm of ovary Personal history of malignant neoplasm of other female genital organs C15.9 C16.9 C17.9 D00.1 D00.2 D05.90 Z85.00 Malignant neoplasm of esophagus, unspecified Malignant neoplasm of stomach, unspecified Carcinoma in situ of stomach Gastric Malignant neoplasm of small intestine, unspecified Carcinoma in situ of esophagus Unspecified type of carcinoma in situ of unspecified breast Personal history of malignant neoplasm of unspecified digestive organ Page 4/7
6 C41.9 C49.9 C C C71.9 C74.90 D05.00 D05.10 D05.90 D09.8 D43.2 D43.4 Z Li-Fraumeni Malignant neoplasm of bone and articular cartilage, unspecified Malignant neoplasm of connective and soft tissue, unspecified Malignant neoplasm of unspecified site of unspecified female breast Malignant neoplasm of unspecified site of unspecified male breast Malignant neoplasm of brain, unspecified Malignant neoplasm of unspecified part of unspecified adrenal gland Lobular carcinoma in situ of unspecified breast Intraductal carcinoma in situ of unspecified breast Unspecified type of carcinoma in situ of unspecified breast Carcinoma in situ of other specified sites Neoplasm of uncertain behavior of brain, unspecified Neoplasm of uncertain behavior of spinal cord Personal history of malignant neoplasm of bone C15.9 C16.9 C17.9 C18.9 C25.9 C54.1 D01.0 D07.0 D07.30 Z80.41 Z85.00 Malignant neoplasm of esophagus, unspecified Malignant neoplasm of stomach, unspecified Malignant neoplasm of colon, unspecified Malignant neoplasm of endometrium Carcinoma in situ of endometrium Lynch Malignant neoplasm of small intestine, unspecified Malignant neoplasm of pancreas, unspecified Carcinoma in situ of colon Carcinoma in situ of unspecified female genital organs Family history of malignant neoplasm of ovary Personal history of malignant neoplasm of unspecified digestive organ Page 5/7
7 Z85.07 Z85.43 Lynch continued Personal history of malignant neoplasm of pancreas Personal history of malignant neoplasm of ovary C25.9 C43.9 D01.7 D01.9 D03.9 D04.9 Z80.8 Z Malignant neoplasm of pancreas, unspecified Malignant melanoma of skin, unspecified Melanoma Carcinoma in situ of other specified digestive organs Carcinoma in situ of digestive organ, unspecified Melanoma in situ, unspecified Carcinoma in situ of skin, unspecified Family history of malignant neoplasm of other organs or systems (skin, melanoma) Personal history of malignant melanoma of skin C25.9 C80.1 D01.7 D01.9 Z85.07 Malignant neoplasm of pancreas, unspecified Pancreatic Malignant (primary) neoplasm, unspecified (adenocarcinoma) Carcinoma in situ of other specified digestive organs (pancreas) Carcinoma in situ of digestive organ, unspecified Personal history of malignant neoplasm of pancreas C61 D07.5 Malignant neoplasm of prostate Carcinoma in situ of prostate Prostate Page 6/7
8 Prostate continued R97.2 Z15.02 Z15.03 Z80.41 Z80.42 Z85.46 Elevated prostate specific antigen [PSA] Genetic susceptibility to malignant neoplasm of ovary Genetic susceptibility to malignant neoplasm of prostate Family history of malignant neoplasm of ovary Family history of malignant neoplasm of prostate Personal history of malignant neoplasm of prostate Z15.01 Z15.02 Z15.03 Z15.09 Z15.81 Z15.89 Single Site Genetic susceptibility to malignant neoplasm of breast Genetic susceptibility to malignant neoplasm of ovary Genetic susceptibility to malignant neoplasm of prostate Genetic susceptibility to other malignant neoplasm Genetic susceptibility to multiple endocrine neoplasia [MEN] Genetic susceptibility to other disease D09.9 Z80.8 Z80.9 Z85.89 Z85.9 Carcinoma in situ, unspecified Other Family history of malignant neoplasm of other organs or systems Family history of malignant neoplasm, unspecified Personal history of malignant neoplasm of other organs and systems Personal history of malignant neoplasm, unspecified Reference: S Clay Blair Blvd, Suite 1400 / Olathe, KS info@intelligene-cg.com (913) Page 7/7
Chapter I Overview Chapter Contents
Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality
ORGAN SYSTEMS OF THE BODY
ORGAN SYSTEMS OF THE BODY DEFINITIONS AND CONCEPTS A. Organ a structure made up of two or more kinds of tissues organized in such a way that they can together perform a more complex function that can any
C a nc e r C e nter. Annual Registry Report
C a nc e r C e nter Annual Registry Report 214 214 Cancer Registry Report Larraine A. Tooker, CTR Please note that the 214 Cancer Registry Annual Report is created in 214, but it reflects data on cases
CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
Description Code Recommendation Description Code. All natural death 001-799 IPH All natural death A00-R99
Natural death Description Code Recommendation Description Code All natural death 001-799 IPH All natural death A00-R99 Infectious and parasitic diseases 001-139 CDC, EUROSTAT, CBS & VG Infectious and parasitic
ENTERAL NUTRITION Policy/CPT ICD-10 ICD-10 Description ICD-9 ICD-9 Description EPA 870001100 N18.6 End stage renal disease 585.
ENTERAL NUTRITION Policy/CPT ICD-10 ICD-10 Description ICD-9 ICD-9 Description EPA 870001100 N18.6 End stage renal disease 585.6 End stage renal disease EPA 870001101 C00.0 Malignant neoplasm of external
LCD for Prostate Specific Antigen (PSA)
LCD for Prostate Specific Antigen (PSA) Applicable CPT Code(s): 84152 Prostate Specific Antigen (PSA); Complexed (Direct Measurement) 84153 Prostate Specific Antigen (PSA); Total 84154 Prostate Specific
Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes
Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes Policy Number: Original Effective Date: MM.02.007 09/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO 09/01/2011
DELRAY MEDICAL CENTER. Cancer Program Annual Report
DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions
The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales
The effect of the introduction of ICD-10 on cancer mortality trends in Anita Brock, Clare Griffiths and Cleo Rooney, Offi ce for INTRODUCTION From January 2001 deaths in have been coded to the Tenth Revision
Common Cancers & Hereditary Syndromes
Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.
Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations
North America Canada Canadian 1951 Schmidt & Popham (1981) 1951 70 9 889 alcoholic men, aged 15 years, admitted to the clinical service of the Addiction Research Foundation of Ontario between Death records
THE CANCER CENTER 2013 ANNUAL REPORT CONTAINING 2012 STATISTICS
THE CANCER CENTER 2013 ANNUAL REPORT CONTAINING 2012 STATISTICS Northside Medical Center Cancer Committee Mission Statement It is the mission of the Cancer Committee to evaluate and monitor the care of
Non-covered ICD-10-CM Codes for All Lab NCDs
Non-covered ICD-10-CM s for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test,
Critical Illness with Term Assurance
AIG Life Critical Illness with Term Assurance Our comprehensive Critical Illness with Term Assurance delivers more value and quality to the customer and their family than ever before. It is designed to
Number. Source: Vital Records, M CDPH
Epidemiology of Cancer in Department of Public Health Revised April 212 Introduction The general public is very concerned about cancer in the community. Many residents believe that cancer rates are high
Organ Systems Overview
E x e r c i s e 2 Organ Systems Overview Time Allotment: 1½ hours (rat dissection: 1 hour; if performing reproductive system dissection, ½ hour each for male and female; dissectible human torso model:
Immunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
67 The Human Skeleton
67 The Human Skeleton Skull SCIENCE EXPLORER Focus on Life Science Prentice-Hall, Inc. Clavicle (collarbone) Scapula (shoulder blade) Carpals Metacarpals Phalanges Femur Tibia Humerus Ulna Sternum (breastbone)
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator November 2015 334 Jefferson Avenue, Scranton,
MODERN IMMUNOHISTOCHEMISTRY
MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,
Name Class Date Laboratory Investigation 24A Chapter 24A: Human Skin
Name Class Date Laboratory Investigation 24A Chapter 24A: Human Skin Human Anatomy & Physiology: Integumentary System You may refer to pages 386-394 in your textbook for a general discussion of the integumentary
Biochemistry of Cancer Cell
Biochemistry of Cancer Cell Prof. Taha Kumosani Prof. Taha Kumosani http://biochemistry4all.com/taha/5.htm Cancer: an Overview Paleopathologists Dinosaur bones Egyptians Papyrus Autopsis Hippocrates Carcinoma
Hospital-Based Tumor Registry. Srinagarind Hospital, Khon Kaen University
Hospital-Based Tumor Registry Srinagarind Hospital, Khon Kaen University Statistical Report 2012 Cancer Unit, Faculty of Medicine Khon Kaen University Khon Kaen, Thailand Tel & Fax:+66(43)-202485 E-mail:
STATISTICAL BRIEF #37
HEALTHCARE COST AND UTILIZATION PROJECT STATISTICAL BRIEF #37 Agency for Healthcare Research and Quality September 2007 Pediatric Hospital Stays for Cancer, 2005 Chaya T. Merrill, M.P.H., Mika Nagamine,
Human Body Systems Project By Eva McLanahan
Human Body Systems Project By Eva McLanahan Students will work in groups to research one of the eleven body systems as found in Holt, Rinehart, and Winston Modern Biology (2002). Research will focus on
CANCER COMMITTEE MEMBERS NORTHWESTERN LAKE FOREST HOSPITAL\ 2010
CANCER COMMITTEE MEMBERS NORTHWESTERN LAKE FOREST HOSPITAL\ 2010 Michael Cochran, MD Susan Balling R.N. Karline Peal RT Stephen Ganshirt M.D. Nancy Bulzoni Emily Rosecrans Joseph Imperato M.D Linda Dickson
Medical Specialties Guide
Medical Specialties Guide Allergy And Immunology Specialists in this field treat disorders related to how the body reacts to foreign substances. They treat such things as seasonal allergies, eczema, asthma,
NEOPLASMS C00 D49. Presented by Jan Halloran CCS
NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through
Cancer Surgery Volume Study: ICD-9 and CPT Codes
This paper contains the ICD-9 diagnostic and procedure codes and the CPT procedure codes used by researchers for a project of the California HealthCare Foundation (CHCF) and the California Office of Statewide
Metastasis. Brookdale Hospital, Brooklyn, New York 11212, USA; 2 Cambridge, MA 02138, USA ma8080@gmail.com
Metastasis Ma Hongbao 1, Margaret Ma 2, Yang Yan 1 1 Brookdale Hospital, Brooklyn, New York 11212, USA; 2 Cambridge, MA 02138, USA ma8080@gmail.com Abstract: Cancer begins when cells in a part of the body
Critical Illness with Term Assurance
AIG Life Critical Illness with Term Assurance Our comprehensive Critical Illness with Term Assurance delivers more value and quality to the customer and their family than ever before. It is designed to
PET (FDG) Scan for Solid Tumors PET (FDG) SCAN FOR SOLID TUMORS HS-112. Policy Number: HS-112. Original Effective Date: 6/18/2009
Easy Choice Health Plan, Inc. Exactus Pharmacy Solutions, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Incorporated WellCare Health Insurance of Arizona, Inc., operating in Hawai i as Ohana
Cancer in Norway 2008
Cancer in Norway 8 Cancer incidence, mortality, survival and prevalence in Norway Special issue: The Janus Serum Bank From sample collection to cancer research Cancer in Norway 8 Editor-in-chief: Freddie
Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013. National Registry of Diseases Office (NRDO)
Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013 National Registry of Diseases Office (NRDO) Released November 3, 2014 Acknowledgement This report was
Billing Guideline. Subject: Colorectal Cancer Screening Exams (Invasive Procedures) Effective Date: 1/1/2012 Last Update Effective: 4/16
Subject: Colorectal Cancer Screening Exams (Invasive Procedures) Effective Date: 1/1/2012 Last Update Effective: 4/16 Billing Guideline Background Health First administers benefit packages with full coverage
New Hampshire Childhood Cancer
Introduction: New Hampshire Childhood Cancer New Hampshire, Childhood Cancer, January 2009 Issue Brief Cancer in children is relatively uncommon, impacting fewer than twenty two of every 100,000 children
Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?
Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or
ICD-10 Codes Utilized by Audiologists
ICD-10 Codes Utilized by Audiologists Introduction Beginning with the first claim filed to all payers on or after October 1, 2015, the ICD-10 codes must be utilized in box 21 A-L on the CMS 1500 claim
National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28)
National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28) Tracking Information Publication Number Manual Section Number 100-3 190.28 Manual Section Title Tumor Antigen by
Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin
A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,
R E X C A N C E R C E N T E R. Annual Report 2012. Rex Cancer Care Committee 2012 On behalf of the Rex Cancer Center & Rex Health Care
R E X C A N C E R C E N T E R Annual Report 2012 Rex Cancer Care Committee 2012 On behalf of the Rex Cancer Center & Rex Health Care An American College of Surgeons Commission on Cancer Accredited Comprehensive
Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010
Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010 This guide has three parts: 1. Information for health professionals 2. Tables
Cancer in Ireland 2013: Annual report of the National Cancer Registry
Cancer in 2013: Annual report of the National Cancer Registry ABBREVIATIONS Acronyms 95% CI 95% confidence interval APC Annual percentage change ASR Age standardised rate (European standard population)
Measure Name: Low Back Pain Imaging Studies Measure Code: LBP Lab Data: N
Measure Name: Low Back Pain Imaging Studies Owner: NCQA (LBP) Measure Code: LBP Lab Data: N Rule Description: General Criteria Summary The percentage of patients 18-50 years of age who had a principal
BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner
BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome Thomas Wiesner Disclosure Listed as co-inventor US patent application US 61/463,389 BAP1 mutational analysis in determining susceptibility
Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November 2008 www.cumbria.nhs.uk
Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November 2008 www.cumbria.nhs.uk 2 Table of contents: Summary... 4 Introduction..6 Cancer Incidence 7 Cancer Mortality....13 Cancer Survival
Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach
Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Publishing Team Erik Tanck (production manager/designer) Joshua Weikersheimer (publisher) Copyright 2006 by the American Society
Avian (parakeet) kidney nephroblastoma, Case #102.18180
1. Avian (parakeet) kidney nephroblastoma, Case #102.18180 Page - 1 2. Avian (parrot) kidney renal cell carcinoma, Case #102.20472... Page - 2 3. Avian (chicken) kidney malignant lymphoma (Mareks Disease)...
MedStar Montgomery Medical Center. Cancer Center 2014 Annual Report
MedStar Montgomery Medical Center Cancer Center 2014 Annual Report 2014 MedStar Montgomery Medical Center Cancer Center Committee Report Cancer Committee Chair s Report According to a recent report from
ANATOMY AND PHYSIOLOGY
ANATOMY AND PHYSIOLOGY Placement: First Year Theory - Anatomy: 60 Physiology: 60 Course Description -The course is designed to assist students to acquire the knowledge of the normal Structure of human
THE HUMAN BODY SYSTEMS
Name Period Date THE HUMAN BODY SYSTEMS System Function Diagram Major Organs Digestive 1. take in food (ingestion) 2. digest food into smaller molecules and absorb nutrients 3. remove undigestable food
The Ontario Cancer Registry moves to the 21 st Century
The Ontario Cancer Registry moves to the 21 st Century Rebuilding the OCR Public Health Ontario Grand Rounds Oct. 14, 2014 Diane Nishri, MSc Mary Jane King, MPH, CTR Outline 1. What is the Ontario Cancer
4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma
Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer
Part 1: Introduction Tell the name of your organ system and describe the major functions.
Team Members: System: Your team s job is prepare a presentation to educate your classmates about one of the body systems that makes up the human body. Your presentation must include the following requirements:
NM- Nuclear Medicine
NM- Nuclear Medicine CODE DESCRIPTION 78000 Thyroid uptake; single determination 78001 Thyroid uptake; multiple determinations 78003 Thyroid uptake; stimulation, suppression or discharge 78006 Thyroid
GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP
GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP WHO IS AT HIGH RISK OF HEREDITARY CANCER? Hereditary Cancer accounts for a small proportion of all cancer or approximately 5-10% THE DEVELOPMENT
STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE. BIOL 207 Human Anatomy
STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE BIOL 207 Human Anatomy Prepared By: Ron Tavernier, PhD School of Science, Health and Criminal Justice Science Department
BIO 137: CHAPTER 1 OBJECTIVES
BIO 137: CHAPTER 1 OBJECTIVES 1. Define the terms anatomy and physiology, and explain their relationship using an example of a human structure with its corresponding function. A. ANATOMY = the study of
THE CANCER CENTER 2014 ANNUAL REPORT CONTAINING 2013 STATISTICS
THE CANCER CENTER 2014 ANNUAL REPORT CONTAINING 2013 STATISTICS Northside Medical Center Cancer Committee Mission Statement It is the mission of the Cancer Committee to evaluate and monitor the care of
NCI Community Cancer Centers Program Program Overview Ascension Health St. Vincent Indianapolis Hospital
A. Name and location of hospital:, Indianapolis, IN B. Name of cancer center: St. Vincent Oncology Center C. Identify PI and key personnel with contact information for each pilot focus areas: a. Disparities
190.25 - Alpha-fetoprotein
Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain
Systems of the Human Body
. s^^-^^. 0^^- B «*-^.^^^--"'- s»'"-^w.^*"' Systems of the Human Body The body is made up of an amazing group of systems. The systems of the body all work together and need each other to keep the body
CMS Limitations Guide Mammograms and Bone Density Radiology Services
CMS Limitations Guide Mammograms and Bone Density Radiology Services Starting July 1, 2008, CMS has placed numerous medical necessity limits on tests and procedures. This reference guide provides you with
Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Jurisdiction Virginia. Retirement Date N/A
Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor
This module consists of four units which will provide the user a basic knowledge of cancer as a disease.
Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define
Introduction to Animal Systems
Human Body Systems Introduction to Animal Systems Recurring Themes in Biology 1. Correlation between structure and function( seen at many levels) 2. Life is organized at many levels from Smallest ----
Cancer in Norway 2011
Cancer in Norway 11 Cancer incidence, mortality, survival and prevalence in Norway Special issue: NORDCAN Cancer data from the Nordic countries Cancer in Norway 11 Editor-in-chief: Inger Kristin Larsen
Medical Surgical Nursing (Elsevier)
1 of 6 I. The Musculoskeletal System Medical Surgical Nursing (Elsevier) 1. Med/Surg: Musculoskeletal System: The Comprehensive Health History 2. Med/Surg: Musculoskeletal System: A Nursing Approach to
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
an Journal of Cancer (2013) 49, 1374 1403 Available at www.sciencedirect.com journalhomepage:www.ejcancer.info Cancer incidence and mortality patterns in : Estimates for 40 countries in 2012 J. Ferlay
Cancer Statistics, 2013
CA CANCER J CLIN 2013;63:11 30 Cancer Statistics, 2013 Rebecca Siegel, MPH 1 ; Deepa Naishadham, MA, MS 2 ; Ahmedin Jemal, DVM, PhD 3 Each year, the American Cancer Society estimates the numbers of new
COLORECTAL CANCER SCREENING
COLORECTAL CANCER SCREENING By Douglas K. Rex, M.D., FACG & Suthat Liangpunsakul, M.D. Division of Gastroenterology and Hepatology, Department of Medicine Indiana University School of Medicine Indianapolis,
Neuroendocrine Tumors
Neuroendocrine Tumors Neuroendocrine tumors arise from cells that release a hormone in response to a signal from the nervous system. Neuro refers to the nervous system. Endocrine refers to the hormones.
Cancer Conferences 2008
2009 Annual Report Cancer Registry Report The Cancer Registry collects data on all cancer patients who were diagnosed and/or treated at East Alabama Medical Center. Diagnostic, therapeutic and outcome
CANCER INCIDENCE RATES IN NORTHEASTERN MINNESOTA. MCSS Epidemiology Report 99:2. September 1999
CANCER INCIDENCE RATES IN NORTHEASTERN MINNESOTA MCSS Epidemiology Report 99: September 999 Minnesota Cancer Surveillance System Chronic Disease And Environmental Epidemiology Section Minnesota Department
Cancer Statistics, 2015
Cancer Statistics, 2015 Rebecca L. Siegel, MPH 1 *; Kimberly D. Miller, MPH 2 ; Ahmedin Jemal, DVM, PhD 3 Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that
Frequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
ADVANCE NOTICE OF EXCESS CLAIM REPORT
ADVANCE NOTICE OF EXCESS CLAIM REPORT Please provide the following information for claimants that 15,000 or more is expected to be paid on. Group Name: Pooling Point: Effective Date: Claimant Information
Finnish Cancer Registry Institute for Statistical and Epidemiological Cancer Research. Survival ratios of cancer patients by area in Finland
Survival ratios of cancer patients by area in Finland Pages 2 14 present the relative survival ratios for patients diagnosed in 2005 2012 and followed-up in 2010 2012 (see Methods p. 15) on different university
ADVANCE NOTICE OF EXCESS CLAIM REPORT
ADVANCE NOTICE OF EXCESS CLAIM REPORT Please provide the following information for excess claims which have paid at 15,000 or more. Group Name: Effective Date: Claimant Information Employee Name: DOB:
Early Prostate Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008
Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008 David R. Risser, M.P.H., Ph.D. David.Risser@dshs.state.tx.us Epidemiologist Cancer Epidemiology and Surveillance Branch
NLSY79 ATTACHMENT 8: HEALTH CODES
NLSY79 ATTACHMENT 8: HEALTH CODES 1 GENERAL INFORMATION ON HEALTH CODES The health section of the NLS survey elicits health problems that limit the amount or kind of work the respondent can do. Those health
CANCER IN CALIFORNIA
CANCER IN CALIFORNIA A N OV E R V I E W O F CA L I FO R N I A S RECENT CA N C E R I N C I D E N C E A N D M O R TA L I T Y 1988-2009 STAT I S T I CS Searching for Causes & Cures KEN MADDY CALIFORNIA CANCER
Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.
Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic
Anatomy and Physiology
Anatomy and Physiology UNIT I: Introduction to Anatomy and Physiology The student will demonstrate an understanding of the anatomic and physiological basis of life and the ability to explain the interdependence
5 Burden of disease and injury
5 Burden of disease and injury 5.1 Overview In this chapter, we present the results of the Australian Burden of Disease and Injury Study for the total disease burden measured in by age, sex and cause for
Canadian Cancer Statistics
Canadian Cancer Statistics 2008 www.cancer.ca PRODUCED BY: CANADIAN CANCER SOCIETY, NATIONAL CANCER INSTITUTE OF CANADA, STATISTICS CANADA, PROVINCIAL/ TERRITORIAL CANCER REGISTRIES, PUBLIC HEALTH AGENCY
The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine
The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
Genetic Testing for Familial Adenomatous Polyposis and MYH-Associated Polyposis (Lynch Syndrome)
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
BRAIN TUMOUR RESEARCH FUNDING FLOWS
BRAIN TUMOUR RESEARCH FUNDING FLOWS Ellen Harries, Iona Joy v London, April 2013 (updated) CONTENTS 1 Research brief and headline findings 2 Research funding for cancer 3 Brain tumour funding compared
Cancer Survival in New Jersey 1979-2005
Cancer Survival in New Jersey 1979-2005 Cancer Epidemiology Services Public Health Services Branch New Jersey Department of Health Chris Chris e, Governor Kim Guadagno, Lt. Governor Mary E. O Dowd, MPH
The Lewin Group undertook the following steps to identify the guidelines relevant to the 11 targeted procedures:
Guidelines The following is a list of proposed medical specialty guidelines that have been found for the 11 targeted procedures to be included in the Medicare Imaging Demonstration. The list includes only
Cancer Facts & Figures 2014
Cancer Facts & Figures 2014 CA 171,730 OR 22,530 WA 38,230 NV 14,450 AK 3,750 ID 7,990 UT 10,780 MT 5,850 WY 2,890 CO 23,810 MN 29,340 IA 17,630 AZ OK 32,830 NM 19,830 AR 10,210 16,520 HI 6,640 ND 3,730
- Slide Seminar - Endocrine pathology in non-endocrine organs. Case 11. Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa
- Slide Seminar - Endocrine pathology in non-endocrine organs Case 11 Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa Dept. of Pathology, Multimedica, Milan, Italy Dept. of Surgical and Morphological
Effusions: Mesothelioma and Metastatic Cancers
Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,
Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center
Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary
Hereditary Breast Cancer Testing. Diagnostic
Hereditary Cancer Testing Diagnostic New solutions for hereditary breast cancer. Identifying and understanding the genetic contribution to breast cancer allows for individualized disease management and
Work-Related Disease in New Zealand
LABOUR AND COMMERCIAL ENVIRONMENT Work-Related Disease in New Zealand The state of play in 2010 MB 12548 AUG 13 Ministry of Business, Innovation and Employment (MBIE) Hīkina Whakatutuki Lifting to make